Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Coenen

Showing results (161-170 of 208) with videos related to

Pageof 21
Sort By:
BMJ (Clinical Research Ed.)|May 2, 2013
Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic studySaskia F van Vugt, Berna D L Broekhuizen, Christine Lammens, et al.
Archives of Public Health = Archives Belges De Sante Publique|June 25, 2026
SARS-CoV-2 breakthrough infection incidence, risk factors, and antibody correlates in Belgian nursing homes residents and staff (2021-2022)Liselore De Rop, Eline Meyers, Natalja Van Biesen, et al.
Lancet (London, England)|September 28, 2025
A clinical decision tool including a decision tree, point-of-care testing of CRP, and safety-netting advice to guide antibiotic prescribing in acutely ill children in primary care in Belgium (ARON): a pragmatic, cluster-randomised, controlled trialJan Yvan Verbakel, Ruben Burvenich, Erinn D'hulster, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 18, 2021
Predicting mortality in intensive care unit patients infected with Klebsiella pneumoniae: A retrospective cohort studyThuy Ngan Tran, Dinh Hoa Vu, Hoang Anh Nguyen, et al.
ERJ Open Research|May 16, 2018
A trial like ALIC<sup>4</sup>E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?Christopher C Butler, Samuel Coenen, Benjamin R Saville, et al.
Family Practice|June 6, 2015
Validity of a clinical model to predict influenza in patients presenting with symptoms of lower respiratory tract infection in primary careSaskia F van Vugt, Berna Dl Broekhuizen, Nicolaas Pa Zuithoff, et al.
BMJ Open|September 19, 2022
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upNiels Adriaenssens, Beatrice Scholtes, Robin Bruyndonckx, et al.
BMJ Open|May 2, 2023
Validation of a rapid SARS-CoV-2 antibody test in general practiceJulie Domen, Jan Yvan Jos Verbakel, Niels Adriaenssens, et al.
Journal of General Internal Medicine|November 7, 2014
Clinicians' views and experiences of interventions to enhance the quality of antibiotic prescribing for acute respiratory tract infectionsSibyl Anthierens, Sarah Tonkin-Crine, Jochen W Cals, et al.
Allergy|April 4, 2020
Prevalence of self-reported and confirmed penicillin allergy in a Belgian outpatient populationAthina L Van Gasse, Redouane Oulkadi, Zakaria Mousati, et al.
Pageof 21

Showing results (161-170 of 208) with videos related to

Sort By:
Pageof 21
BMJ (Clinical Research Ed.)|May 2, 2013
Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic studySaskia F van Vugt, Berna D L Broekhuizen, Christine Lammens, et al.
Archives of Public Health = Archives Belges De Sante Publique|June 25, 2026
SARS-CoV-2 breakthrough infection incidence, risk factors, and antibody correlates in Belgian nursing homes residents and staff (2021-2022)Liselore De Rop, Eline Meyers, Natalja Van Biesen, et al.
Lancet (London, England)|September 28, 2025
A clinical decision tool including a decision tree, point-of-care testing of CRP, and safety-netting advice to guide antibiotic prescribing in acutely ill children in primary care in Belgium (ARON): a pragmatic, cluster-randomised, controlled trialJan Yvan Verbakel, Ruben Burvenich, Erinn D'hulster, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 18, 2021
Predicting mortality in intensive care unit patients infected with Klebsiella pneumoniae: A retrospective cohort studyThuy Ngan Tran, Dinh Hoa Vu, Hoang Anh Nguyen, et al.
ERJ Open Research|May 16, 2018
A trial like ALIC<sup>4</sup>E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?Christopher C Butler, Samuel Coenen, Benjamin R Saville, et al.
Family Practice|June 6, 2015
Validity of a clinical model to predict influenza in patients presenting with symptoms of lower respiratory tract infection in primary careSaskia F van Vugt, Berna Dl Broekhuizen, Nicolaas Pa Zuithoff, et al.
BMJ Open|September 19, 2022
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upNiels Adriaenssens, Beatrice Scholtes, Robin Bruyndonckx, et al.
BMJ Open|May 2, 2023
Validation of a rapid SARS-CoV-2 antibody test in general practiceJulie Domen, Jan Yvan Jos Verbakel, Niels Adriaenssens, et al.
Journal of General Internal Medicine|November 7, 2014
Clinicians' views and experiences of interventions to enhance the quality of antibiotic prescribing for acute respiratory tract infectionsSibyl Anthierens, Sarah Tonkin-Crine, Jochen W Cals, et al.
Allergy|April 4, 2020
Prevalence of self-reported and confirmed penicillin allergy in a Belgian outpatient populationAthina L Van Gasse, Redouane Oulkadi, Zakaria Mousati, et al.
Pageof 21